AI Engines For more Details: Perplexity Kagi Labs You
Weight Management: A balanced intake of protein and carbohydrates, along with healthy fats, can support weight management efforts. Protein helps promote satiety and preserves lean muscle mass, while carbohydrates provide energy for physical activity. By focusing on nutrient-dense foods and controlling portion sizes, this diet may help individuals achieve and maintain a healthy weight.
Blood Sugar Control: Moderate-carbohydrate intake can help stabilize blood sugar levels, particularly when the carbohydrates come from whole grains, fruits, vegetables, and legumes. Pairing carbohydrates with protein and healthy fats can further slow down the absorption of glucose into the bloodstream, reducing blood sugar spikes and improving glycemic control, which is beneficial for individuals with diabetes or insulin resistance.
Heart Health: Consuming moderate amounts of protein and carbohydrates, along with heart-healthy fats like those found in nuts, seeds, avocados, and olive oil, can support cardiovascular health. This dietary pattern may help lower LDL cholesterol levels, reduce inflammation, and improve markers of heart disease risk, such as blood pressure and triglyceride levels.
Muscle Health: Adequate protein intake is essential for muscle repair, maintenance, and growth. A moderate-protein diet provides the necessary amino acids to support muscle health, especially when combined with regular physical activity. It can help prevent muscle loss and promote muscle strength and function, which is particularly important for older adults to maintain mobility and independence.
Energy Levels: Carbohydrates are the body's primary source of energy, and a moderate intake can provide sustained energy levels throughout the day. Including complex carbohydrates like whole grains, fruits, and vegetables in the diet can help regulate blood sugar levels and prevent energy crashes often associated with high-sugar, low-fiber foods.
Digestive Health: A balanced intake of protein and carbohydrates, along with fiber-rich foods like fruits, vegetables, and whole grains, supports digestive health and regular bowel movements. Fiber promotes satiety, aids in digestion, and helps maintain a healthy gut microbiome, reducing the risk of constipation, bloating, and other digestive issues.
Nutrient Absorption: Consuming a variety of foods from different food groups ensures adequate intake of essential nutrients like vitamins, minerals, and antioxidants. A moderate-protein, moderate-carbohydrate diet encourages the consumption of nutrient-dense foods, which can support overall health and immune function, and reduce the risk of nutrient deficiencies.
Rank | Probiotic | Impact |
---|---|---|
species | Bifidobacterium adolescentis | Increases |
species | Bifidobacterium bifidum | Increases |
species | Bifidobacterium breve | Increases |
species | Bifidobacterium catenulatum | Increases |
species | Bifidobacterium longum | Increases |
species | Bifidobacterium pseudocatenulatum | Increases |
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
---|---|---|---|
Acne | 0.6 | 0.6 | |
ADHD | 0.6 | 4.2 | -6 |
Allergic Rhinitis (Hay Fever) | 1.4 | 0.2 | 6 |
Allergies | 1.4 | 0.6 | 1.33 |
Allergy to milk products | 1.8 | 1.8 | |
Alopecia (Hair Loss) | 0.6 | -0.6 | |
Alzheimer's disease | 2 | 1.4 | 0.43 |
Amyotrophic lateral sclerosis (ALS) Motor Neuron | 0.6 | 0.6 | 0 |
Ankylosing spondylitis | 0.6 | 1.4 | -1.33 |
Asthma | 1.2 | 1.2 | 0 |
Atherosclerosis | 0.6 | -0.6 | |
Atrial fibrillation | 0.6 | 2 | -2.33 |
Autism | 4 | 2.8 | 0.43 |
Barrett esophagus cancer | 1.2 | 0.2 | 5 |
Bipolar Disorder | 0.2 | 0.6 | -2 |
Brain Trauma | 1.8 | -1.8 | |
Breast Cancer | 0.6 | 0.6 | 0 |
Carcinoma | 0.6 | 1.2 | -1 |
Celiac Disease | 2 | 1.2 | 0.67 |
Cerebral Palsy | 0.8 | -0.8 | |
Chronic Fatigue Syndrome | 0.8 | 1 | -0.25 |
Chronic Kidney Disease | 0.6 | 0.2 | 2 |
Chronic Obstructive Pulmonary Disease (COPD) | 0.8 | -0.8 | |
Chronic Urticaria (Hives) | 0.2 | -0.2 | |
Coagulation / Micro clot triggering bacteria | 0.6 | 0.6 | |
Colorectal Cancer | 0.6 | 2 | -2.33 |
Constipation | 0.3 | 0.3 | |
Coronary artery disease | 0.2 | 0.2 | 0 |
COVID-19 | 1.2 | 1.8 | -0.5 |
Crohn's Disease | 3.2 | 2.6 | 0.23 |
cystic fibrosis | 0.6 | 0.6 | |
deep vein thrombosis | 0.6 | 0.6 | |
Depression | 3.4 | 4.5 | -0.32 |
Dermatomyositis | 0.6 | 0.6 | |
Eczema | 2.4 | 0.2 | 11 |
Endometriosis | 1 | 0.8 | 0.25 |
Eosinophilic Esophagitis | 0.2 | 0.2 | |
Epilepsy | 1.2 | 1.8 | -0.5 |
Fibromyalgia | 0.6 | 0.6 | |
Functional constipation / chronic idiopathic constipation | 1.5 | 0.8 | 0.88 |
gallstone disease (gsd) | 0.6 | 0.2 | 2 |
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus | 0.2 | -0.2 | |
Generalized anxiety disorder | 0.8 | 0.8 | |
Glioblastoma | 0.2 | 0.2 | |
Gout | 0.2 | -0.2 | |
Graves' disease | 1.2 | 0.6 | 1 |
Halitosis | 0.8 | -0.8 | |
Hashimoto's thyroiditis | 0.6 | 0.8 | -0.33 |
Hemorrhoidal disease, Hemorrhoids, Piles | 0.2 | 0.2 | |
Hidradenitis Suppurativa | 0.2 | 0.2 | |
Histamine Issues,Mast Cell Issue, DAO Insufficiency | 0.6 | 0.6 | 0 |
hypercholesterolemia (High Cholesterol) | 0.6 | 0.6 | |
hyperglycemia | 0.6 | 0.6 | |
Hyperlipidemia (High Blood Fats) | 0.6 | -0.6 | |
hypertension (High Blood Pressure | 0.8 | 1.2 | -0.5 |
Hypothyroidism | 0.6 | 0.6 | |
Hypoxia | 0.2 | -0.2 | |
IgA nephropathy (IgAN) | 1.4 | 1.4 | |
Inflammatory Bowel Disease | 1 | 0.6 | 0.67 |
Insomnia | 0.6 | -0.6 | |
Intelligence | 0.6 | 0.6 | |
Irritable Bowel Syndrome | 0.8 | 1 | -0.25 |
Liver Cirrhosis | 2.2 | 2.2 | 0 |
Long COVID | 5.2 | 2.7 | 0.93 |
Low bone mineral density | 0.2 | 0.2 | |
ME/CFS with IBS | 0.6 | 0.6 | |
ME/CFS without IBS | 0.6 | 0.6 | |
Menopause | 0.2 | 0.4 | -1 |
Metabolic Syndrome | 3.2 | 4.6 | -0.44 |
Mood Disorders | 4.3 | 5.1 | -0.19 |
multiple chemical sensitivity [MCS] | 0.8 | -0.8 | |
Multiple Sclerosis | 0.8 | -0.8 | |
Multiple system atrophy (MSA) | 1 | 0.2 | 4 |
Neuropathy (all types) | 0.2 | -0.2 | |
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 1.4 | 1.2 | 0.17 |
NonCeliac Gluten Sensitivity | 0.6 | 0.6 | |
Obesity | 2 | 0.6 | 2.33 |
obsessive-compulsive disorder | 0.8 | 0.2 | 3 |
Osteoarthritis | 0.2 | 0.2 | |
Osteoporosis | 0.8 | -0.8 | |
Parkinson's Disease | 0.4 | 1.4 | -2.5 |
Polycystic ovary syndrome | 0.6 | 0.6 | |
Postural orthostatic tachycardia syndrome | 0.6 | 0.6 | |
Premenstrual dysphoric disorder | 0.6 | 0.6 | 0 |
primary biliary cholangitis | 0.6 | 0.6 | 0 |
Psoriasis | 0.6 | 1.8 | -2 |
rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 1.6 | 2 | -0.25 |
Rosacea | 1.2 | 0.6 | 1 |
Schizophrenia | 2.1 | 1.6 | 0.31 |
Sjögren syndrome | 0.8 | 1 | -0.25 |
Sleep Apnea | 0.6 | 1.6 | -1.67 |
Small Intestinal Bacterial Overgrowth (SIBO) | 0.2 | 0.2 | |
Stress / posttraumatic stress disorder | 0.8 | 1.2 | -0.5 |
Systemic Lupus Erythematosus | 1.2 | 0.8 | 0.5 |
Tic Disorder | 0.9 | 0.9 | |
Type 1 Diabetes | 1.6 | 0.2 | 7 |
Type 2 Diabetes | 1.8 | 4 | -1.22 |
Ulcerative colitis | 1.6 | 1.5 | 0.07 |
Unhealthy Ageing | 0.6 | 0.2 | 2 |
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.